These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 33892395)

  • 1. Hybrid organic/inorganic hybrid surface technology for increasing the performance of LC/MS(MS)-based drug metabolite identification studies: Application to gefitinib and metabolites in mouse plasma and urine.
    Plumb RS; Gethings LA; King A; Mullin LG; Maker G; Trengove R; Wilson ID
    J Pharm Biomed Anal; 2021 Jun; 200():114076. PubMed ID: 33892395
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improving LC/MS/MS-based bioanalytical method performance and sensitivity via a hybrid surface barrier to mitigate analyte - Metal surface interactions.
    Tanna N; Mullin LG; Rainville PD; Wilson ID; Plumb RS
    J Chromatogr B Analyt Technol Biomed Life Sci; 2021 Aug; 1179():122825. PubMed ID: 34218093
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High perfomance liquid chromatography in pharmaceutical analyses.
    Nikolin B; Imamović B; Medanhodzić-Vuk S; Sober M
    Bosn J Basic Med Sci; 2004 May; 4(2):5-9. PubMed ID: 15629016
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of hybrid surface technology for the analysis of the B-group vitamins by LC-ESI-MS/MS.
    Yang J; Wilson I; Rainville P
    J Chromatogr B Analyt Technol Biomed Life Sci; 2022 Jul; 1204():123336. PubMed ID: 35709669
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Simultaneous determination of gefitinib and its major metabolites in mouse plasma by HPLC-MS/MS and its application to a pharmacokinetics study.
    Zheng N; Zhao C; He XR; Jiang ST; Han SY; Xu GB; Li PP
    J Chromatogr B Analyt Technol Biomed Life Sci; 2016 Feb; 1011():215-22. PubMed ID: 26795401
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Access to the Phospho-proteome via the Mitigation of Peptide-Metal Interactions.
    Hughes CJ; Gethings LA; Wilson ID; Plumb RS
    J Chromatogr A; 2022 Jun; 1673():463024. PubMed ID: 35490462
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Optimization of a two-dimensional liquid chromatography-supercritical fluid chromatography-mass spectrometry (2D-LC-SFS-MS) system to assess "in-vivo" inter-conversion of chiral drug molecules.
    Goel M; Larson E; Venkatramani CJ; Al-Sayah MA
    J Chromatogr B Analyt Technol Biomed Life Sci; 2018 May; 1084():89-95. PubMed ID: 29579733
    [TBL] [Abstract][Full Text] [Related]  

  • 8. General unknown screening in hair by liquid chromatography-hybrid quadrupole time-of-flight mass spectrometry (LC-QTOF-MS).
    Broecker S; Herre S; Pragst F
    Forensic Sci Int; 2012 May; 218(1-3):68-81. PubMed ID: 22036310
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rapid determination of the pharmacokinetics and metabolic fate of gefitinib in the mouse using a combination of UPLC/MS/MS, UPLC/QToF/MS, and ion mobility (IM)-enabled UPLC/QToF/MS.
    Molloy BJ; King A; Mullin LG; Gethings LA; Riley R; Plumb RS; Wilson ID
    Xenobiotica; 2021 Apr; 51(4):434-446. PubMed ID: 33280466
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development and validation of a sensitive LC-MS/MS method for determination of gefitinib and its major metabolites in human plasma and its application in non-small cell lung cancer patients.
    Guan S; Chen X; Wang F; Xin S; Feng W; Zhu X; Liu S; Zhuang W; Zhou S; Huang M; Wang X; Zhang L
    J Pharm Biomed Anal; 2019 Aug; 172():364-371. PubMed ID: 31096095
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A validated high-performance liquid chromatography-tandem mass spectrometry method for quantification of gefitinib and its main metabolites in xenograft mouse tumor: Application to a pharmacokinetics study.
    Zhao C; Zheng N; Yang F; Han SY; Li PP
    Biomed Chromatogr; 2019 Nov; 33(11):e4638. PubMed ID: 31261446
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An introduction to hybrid ion trap/time-of-flight mass spectrometry coupled with liquid chromatography applied to drug metabolism studies.
    Liu ZY
    J Mass Spectrom; 2012 Dec; 47(12):1627-42. PubMed ID: 23280752
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantitation of drug metabolites in the absence of pure metabolite standards by high-performance liquid chromatography coupled with a chemiluminescence nitrogen detector and mass spectrometer.
    Deng Y; Wu JT; Zhang H; Olah TV
    Rapid Commun Mass Spectrom; 2004; 18(15):1681-5. PubMed ID: 15282765
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Using Hybrid Organic-Inorganic Surface Technology to Mitigate Analyte Interactions with Metal Surfaces in UHPLC.
    DeLano M; Walter TH; Lauber MA; Gilar M; Jung MC; Nguyen JM; Boissel C; Patel AV; Bates-Harrison A; Wyndham KD
    Anal Chem; 2021 Apr; 93(14):5773-5781. PubMed ID: 33798331
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolite characterization in drug discovery utilizing robotic liquid-handling, quadruple time-of-flight mass spectrometry and in-silico prediction.
    Nassar AE; Adams PE
    Curr Drug Metab; 2003 Aug; 4(4):259-71. PubMed ID: 12871044
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification and structural characterization of in vivo metabolites of balofloxacin in rat plasma, urine and feces samples using Q-TOF/LC/ESI/MS/MS : In silico toxicity studies.
    Shankar G; Borkar RM; Udutha S; Anagoni SP; Srinivas R
    J Pharm Biomed Anal; 2018 Sep; 159():200-211. PubMed ID: 29990887
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increasing throughput and information content for in vitro drug metabolism experiments using ultra-performance liquid chromatography coupled to a quadrupole time-of-flight mass spectrometer.
    Castro-Perez J; Plumb R; Granger JH; Beattie I; Joncour K; Wright A
    Rapid Commun Mass Spectrom; 2005; 19(6):843-8. PubMed ID: 15723446
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Broad spectrum drug identification directly from urine, using liquid chromatography-tandem mass spectrometry.
    Fitzgerald RL; Rivera JD; Herold DA
    Clin Chem; 1999 Aug; 45(8 Pt 1):1224-34. PubMed ID: 10430788
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Re-Examining the Impact of Minimal Scans in Liquid Chromatography-Mass Spectrometry Analysis.
    Cai J; Yan Z
    J Am Soc Mass Spectrom; 2021 Aug; 32(8):2110-2122. PubMed ID: 34190546
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.